X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15404) 15404
Book Review (2893) 2893
Publication (1419) 1419
Book Chapter (58) 58
Conference Proceeding (38) 38
Magazine Article (26) 26
Dissertation (21) 21
Web Resource (7) 7
Reference (6) 6
Government Document (3) 3
Paper (3) 3
Book / eBook (1) 1
Data Set (1) 1
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12225) 12225
humans (12166) 12166
imatinib mesylate (11753) 11753
benzamides (6844) 6844
oncology (5546) 5546
male (5088) 5088
pyrimidines - therapeutic use (5001) 5001
piperazines - therapeutic use (4742) 4742
female (4689) 4689
imatinib (4671) 4671
antineoplastic agents - therapeutic use (4332) 4332
middle aged (4053) 4053
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3766) 3766
adult (3506) 3506
hematology (3393) 3393
chronic myelogenous leukemia (3071) 3071
aged (3024) 3024
chronic myeloid-leukemia (2816) 2816
pyrimidines - pharmacology (2541) 2541
chronic myeloid leukemia (2401) 2401
piperazines - pharmacology (2352) 2352
treatment outcome (2307) 2307
cancer (2291) 2291
animals (2238) 2238
protein kinase inhibitors - therapeutic use (2120) 2120
leukemia (1738) 1738
bcr-abl (1682) 1682
antineoplastic agents - pharmacology (1662) 1662
leukemia, myelogenous, chronic, bcr-abl positive - genetics (1648) 1648
protein-tyrosine kinases - antagonists & inhibitors (1619) 1619
mutation (1611) 1611
therapy (1517) 1517
pyrimidines - administration & dosage (1479) 1479
gastrointestinal stromal tumors - drug therapy (1400) 1400
prognosis (1367) 1367
piperazines - administration & dosage (1366) 1366
tyrosine kinase (1360) 1360
gastrointestinal stromal tumors (1340) 1340
tyrosine kinase inhibitor (1335) 1335
care and treatment (1317) 1317
mice (1303) 1303
pyrimidines - adverse effects (1273) 1273
leukemia, myelogenous, chronic, bcr-abl positive - pathology (1264) 1264
fusion proteins, bcr-abl - genetics (1232) 1232
protein kinase inhibitors - pharmacology (1231) 1231
abridged index medicus (1230) 1230
drug resistance, neoplasm (1210) 1210
aged, 80 and over (1183) 1183
tumors (1181) 1181
research (1172) 1172
c-kit (1171) 1171
dasatinib (1165) 1165
cell line, tumor (1152) 1152
hemic and lymphatic diseases (1152) 1152
mesylate (1145) 1145
piperazines - adverse effects (1139) 1139
adolescent (1093) 1093
pharmacology & pharmacy (1089) 1089
antineoplastic agents - adverse effects (1078) 1078
antineoplastic agents (1076) 1076
medicine & public health (1075) 1075
tyrosine (1072) 1072
analysis (1047) 1047
cml (1033) 1033
antineoplastic agents - administration & dosage (981) 981
young adult (972) 972
gastrointestinal stromal tumors - pathology (964) 964
resistance (963) 963
antimitotic agents (961) 961
apoptosis (960) 960
gist (956) 956
proto-oncogene proteins c-kit - genetics (912) 912
drug therapy (887) 887
tyrosine kinase inhibitors (887) 887
expression (883) 883
chemotherapy (863) 863
gastrointestinal stromal tumor (848) 848
apoptosis - drug effects (835) 835
surgery (830) 830
diagnosis (818) 818
hematology, oncology and palliative medicine (817) 817
cell biology (808) 808
retrospective studies (793) 793
benzamides - therapeutic use (768) 768
kit (763) 763
genetic aspects (754) 754
philadelphia-chromosome (747) 747
kinases (746) 746
neoplasms (746) 746
in-vitro (743) 743
health aspects (729) 729
mutations (729) 729
fusion proteins, bcr-abl - metabolism (717) 717
survival (692) 692
imatinib mesylate - therapeutic use (690) 690
follow-up studies (685) 685
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (679) 679
nilotinib (678) 678
article (668) 668
pathology (655) 655
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14126) 14126
Japanese (360) 360
Chinese (292) 292
French (223) 223
German (152) 152
Spanish (96) 96
Korean (48) 48
Russian (41) 41
Italian (29) 29
Polish (29) 29
Hungarian (20) 20
Portuguese (20) 20
Czech (15) 15
Danish (10) 10
Dutch (9) 9
Croatian (7) 7
Turkish (6) 6
Swedish (5) 5
Finnish (3) 3
Hebrew (3) 3
Romanian (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Norwegian (2) 2
Slovak (2) 2
Lithuanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 03/2013, Volume 127, Issue 10, pp. 1128 - 1138
Journal Article
Annals of Surgery, ISSN 0003-4932, 09/2013, Volume 258, Issue 3, pp. 422 - 428
Journal Article
Recent Results in Cancer Research, ISSN 0080-0015, 2018, Volume 212, pp. 1 - 27
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 09/2007, Volume 102, Issue 6, pp. 1749 - 1757
Imatinib, a protein tyrosine kinase inhibitor, may prevent the growth of glioblastoma cells. Unfortunately, its brain distribution is restricted by... 
CGP74588 | mouse | p‐glycoprotein | imatinib | blood–brain barrier | breast cancer resistance protein | Imatinib | Blood-brain barrier | Mouse | Breast cancer resistance protein | p-glycoproteinz | blood-brain barrier | CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | p-glycoprotein | C-KIT | DRUG-RESISTANCE | DEFICIENT MICE | GF120918 | NEUROSCIENCES | REVERSAL | IN-VITRO | PHARMACOKINETICS | TYROSINE KINASE INHIBITOR | MULTIDRUG-RESISTANCE | Male | Piperazines - metabolism | Cyclosporins - pharmacology | Pyrimidines - metabolism | Quinolines - pharmacology | Antineoplastic Agents - metabolism | Brain - metabolism | Dose-Response Relationship, Drug | Brain - blood supply | ATP Binding Cassette Transporter, Subfamily B, Member 1 | ATP-Binding Cassette Transporters - genetics | Biological Transport, Active - physiology | ATP-Binding Cassette Transporters - metabolism | Dibenzocycloheptenes - pharmacology | ATP Binding Cassette Transporter, Subfamily B - genetics | Piperazines - pharmacokinetics | Immunosuppressive Agents - pharmacology | ATP Binding Cassette Transporter, Subfamily G, Member 2 | Tetrahydroisoquinolines - pharmacology | Biological Transport, Active - drug effects | Enzyme Inhibitors - pharmacology | Blood-Brain Barrier - drug effects | Imatinib Mesylate | ATP Binding Cassette Transporter, Subfamily B - metabolism | Blood-Brain Barrier - metabolism | Mice, Knockout | Brain - drug effects | Animals | ATP Binding Cassette Transporter, Subfamily B - antagonists & inhibitors | Acridines - pharmacology | Pyrimidines - pharmacokinetics | Mice | Benzamides | ATP-Binding Cassette Transporters - antagonists & inhibitors | Physiological aspects | Breast cancer | Proteins | Neurosciences | Inhibitor drugs | Rodents | Biochemistry | Glycoproteins | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 11/2004, Volume 101, Issue 9, pp. 2086 - 2097
Journal Article
Journal Article
The Journal of Immunology, ISSN 0022-1767, 11/2008, Volume 181, Issue 10, pp. 6955 - 6963
Journal Article
Nature Medicine, ISSN 1078-8956, 08/2006, Volume 12, Issue 8, pp. 908 - 916
Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia. Here we report ten... 
CHRONIC MYELOGENOUS LEUKEMIA | ADJUVANT CHEMOTHERAPY | MEDICINE, RESEARCH & EXPERIMENTAL | C-ABL | ABL TYROSINE KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | N-TERMINAL KINASE | NEURONAL CELL-DEATH | ENDOPLASMIC-RETICULUM STRESS | HER2-POSITIVE BREAST-CANCER | CHRONIC MYELOID-LEUKEMIA | CELL BIOLOGY | UNFOLDED PROTEIN RESPONSE | Mitochondria, Heart - ultrastructure | Piperazines - administration & dosage | Calcium - metabolism | Mitochondria, Heart - pathology | Sarcoplasmic Reticulum - drug effects | Humans | Piperazines - toxicity | Antineoplastic Agents - administration & dosage | Mitochondria, Heart - drug effects | Ventricular Dysfunction, Left - chemically induced | Antineoplastic Agents - toxicity | Dose-Response Relationship, Drug | Mitochondrial Membranes - drug effects | Pyrimidines - toxicity | Time Factors | Adenosine Triphosphatases - analysis | Antineoplastic Agents - adverse effects | Sarcoplasmic Reticulum - ultrastructure | Antineoplastic Agents - pharmacology | Cell Death - drug effects | Membrane Potentials - drug effects | Severity of Illness Index | Cytochromes c - secretion | Echocardiography | Pyrimidines - administration & dosage | Mice, Inbred C57BL | Cells, Cultured | Injections, Intraperitoneal | Adenosine Triphosphatases - metabolism | Heart Failure - pathology | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - adverse effects | Piperazines - pharmacology | Ventricular Dysfunction, Left - physiopathology | Myocytes, Cardiac - pathology | Animals | Myocytes, Cardiac - drug effects | Cell Membrane Permeability - drug effects | Pyrimidines - adverse effects | Sarcoplasmic Reticulum - pathology | Mice | Benzamides | Myocytes, Cardiac - ultrastructure | Heart Failure - chemically induced | Heart failure | Chemotherapy | Side effects | Inhibitor drugs | Toxicity | Cardiovascular disease | Cancer | Index Medicus
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2011, Volume 70, Issue 6, pp. 1003 - 1009
Journal Article
Cancer, ISSN 0008-543X, 08/2008, Volume 113, Issue 4, pp. 723 - 732
Journal Article
14.